Aaron Bonner-Jackson, Ph.D. - Publications

Affiliations: 
Psychology Washington University, Saint Louis, St. Louis, MO 
Area:
Psychopathology, Schizophrenia, Cognition

21/30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Pillai JA, Bonner-Jackson A, Floden D, Fernandez H, Leverenz JB. Lack of Accurate Self-appraisal is Equally Likely in MCI from Parkinson's Disease and Alzheimer's Disease. Movement Disorders Clinical Practice. 5: 283-289. PMID 30363404 DOI: 10.1002/Mdc3.12606  0.376
2017 Vogel S, Shan G, Bird C, Bonner-Jackson A, Miller JB, Banks SJ. [P2-283]: THE RELATIONSHIP AMONG MEMORY PERFORMANCE AND HIPPOCAMPAL SUBREGION VOLUMES IN A MEMORY CLINIC POPULATION Alzheimer's & Dementia. 13: P723-P723. DOI: 10.1016/J.Jalz.2017.06.936  0.361
2016 Pillai JA, Butler RS, Bonner-Jackson A, Leverenz JB. Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy Cohort. Dementia and Geriatric Cognitive Disorders. 42: 106-116. PMID 27623397 DOI: 10.1159/000448243  0.342
2016 Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, Jones SE, Ehlers JP, Leverenz JB. Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia. American Journal of Alzheimer's Disease and Other Dementias. PMID 26888864 DOI: 10.1177/1533317515628053  0.338
2016 Pillai JA, Bonner-Jackson A, Floden D, Leverenz JB. P2-337: Anosognosia in Amnestic, Non-Amnestic and Parkinson's Disease Mild Cognitive Impairment has Different Underlying Mechanisms Alzheimer's & Dementia. 12: P771-P772. DOI: 10.1016/J.Jalz.2016.06.1467  0.381
2015 Bonner-Jackson A, Mahmoud S, Miller J, Banks SJ. Verbal and non-verbal memory and hippocampal volumes in a memory clinic population. Alzheimer's Research & Therapy. 7: 61. PMID 26468086 DOI: 10.1186/S13195-015-0147-9  0.434
2015 Pillai JA, Bonner-Jackson A. Review of information and communication technology devices for monitoring functional and cognitive decline in Alzheimer's disease clinical trials. Journal of Healthcare Engineering. 6: 71-83. PMID 25708378 DOI: 10.1260/2040-2295.6.1.71  0.358
2015 Rao SM, Bonner-Jackson A, Nielson KA, Seidenberg M, Smith JC, Woodard JL, Durgerian S. Genetic risk for Alzheimer's disease alters the five-year trajectory of semantic memory activation in cognitively intact elders. Neuroimage. 111: 136-46. PMID 25687593 DOI: 10.1016/J.Neuroimage.2015.02.011  0.454
2015 Pillai JA, Butler RS, Bonner-Jackson A, Leverenz JB. P1-219: Slower annual rate of cognitive and functional decline in mixed dementia compared to pure Alzheimer's dementia relates to lower braak stage of Alzheimer's neuropathology Alzheimer's & Dementia. 11: P435-P435. DOI: 10.1016/J.Jalz.2015.06.419  0.366
2014 Pillai JA, Bonner-Jackson A, Walker E, Mourany L, Cummings JL. Higher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 38: 224-33. PMID 24903099 DOI: 10.1159/000362715  0.45
2013 Bonner-Jackson A, Long JD, Westervelt H, Tremont G, Aylward E, Paulsen JS. Cognitive reserve and brain reserve in prodromal Huntington's disease. Journal of the International Neuropsychological Society : Jins. 19: 739-50. PMID 23702309 DOI: 10.1017/S1355617713000507  0.391
2013 Pillai J, Bermel R, Bonner-Jackson A, Jones S, Rae-Grant A. P1-180: Retinal changes in amnestic mild cognitive impairment Alzheimer's & Dementia. 9: P214-P214. DOI: 10.1016/J.Jalz.2013.05.403  0.355
2013 Banks S, Bonner-Jackson A. P4-182: Episodic memory performance and hippocampal volumes among people seeking care at a memory clinic Alzheimer's & Dementia. 9: P772-P772. DOI: 10.1016/J.Jalz.2013.05.1573  0.366
2012 Bonner-Jackson A, Okonkwo O, Tremont G. Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 20: 584-93. PMID 21685781 DOI: 10.1097/Jgp.0B013E3182203C32  0.395
2011 Bonner-Jackson A, Barch DM. Strategic manipulations for associative memory and the role of verbal processing abilities in schizophrenia. Journal of the International Neuropsychological Society : Jins. 17: 796-806. PMID 21729401 DOI: 10.1017/S1355617711000749  0.572
2011 Rosen C, Grossman LS, Harrow M, Bonner-Jackson A, Faull R. Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder. Comprehensive Psychiatry. 52: 126-31. PMID 21295217 DOI: 10.1016/J.Comppsych.2010.06.005  0.373
2010 Bonner-Jackson A, Grossman LS, Harrow M, Rosen C. Neurocognition in schizophrenia: a 20-year multi-follow-up of the course of processing speed and stored knowledge. Comprehensive Psychiatry. 51: 471-9. PMID 20728003 DOI: 10.1016/J.Comppsych.2010.02.005  0.469
2008 Bonner-Jackson A, Yodkovik N, Csernansky JG, Barch DM. Episodic memory in schizophrenia: the influence of strategy use on behavior and brain activation. Psychiatry Research. 164: 1-15. PMID 18790618 DOI: 10.1016/J.Pscychresns.2007.12.012  0.562
2007 Bonner-Jackson A, Csernansky JG, Barch DM. Levels-of-processing effects in first-degree relatives of individuals with schizophrenia. Biological Psychiatry. 61: 1141-7. PMID 17123479 DOI: 10.1016/J.Biopsych.2006.07.006  0.562
2005 Bonner-Jackson A, Haut K, Csernansky JG, Barch DM. The influence of encoding strategy on episodic memory and cortical activity in schizophrenia. Biological Psychiatry. 58: 47-55. PMID 15992522 DOI: 10.1016/J.Biopsych.2005.05.011  0.554
2002 Salisbury DF, Shenton ME, Griggs CB, Bonner-Jackson A, McCarley RW. Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Archives of General Psychiatry. 59: 686-94. PMID 12150644 DOI: 10.1001/Archpsyc.59.8.686  0.46
Low-probability matches (unlikely to be authored by this person)
2022 Krishnan K, Miller AK, Reiter K, Bonner-Jackson A. Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 35136912 DOI: 10.1093/arclin/acac004  0.283
2019 Pillai JA, Bonner-Jackson A, Bekris LM, Safar J, Bena J, Leverenz JB. Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31306137 DOI: 10.3233/Jad-190519  0.265
2021 Pillai JA, Bena J, Bonner-Jackson A, Leverenz JB. Impact of APOE ε4 genotype on initial cognitive symptoms differs for Alzheimer's and Lewy body neuropathology. Alzheimer's Research & Therapy. 13: 31. PMID 33485373 DOI: 10.1186/s13195-021-00771-1  0.263
2018 Uchida A, Pillai JA, Bermel R, Bonner-Jackson A, Rae-Grant A, Fernandez H, Bena J, Jones SE, Leverenz JB, Srivastava SK, Ehlers JP. Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease. Investigative Ophthalmology & Visual Science. 59: 2768-2777. PMID 29860463 DOI: 10.1167/Iovs.17-23240  0.251
2020 Pillai JA, Bena J, Bebek G, Bekris LM, Bonner-Jackson A, Kou L, Pai A, Sørensen L, Neilsen M, Rao SM, Chance M, Lamb BT, Leverenz JB. Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer's disease. Annals of Clinical and Translational Neurology. PMID 32634865 DOI: 10.1002/Acn3.51109  0.207
2012 Rosen C, Grossman LS, Harrow M, Bonner-Jackson A, Faull R. Valor diagnóstico y pronóstico de los síntomas de primer orden de Schneider: un estudio longitudinal de 20 años de la esquizofrenia y el trastorno bipolar Psiquiatría BiolóGica. 19: 110-115. DOI: 10.1016/J.Psiq.2012.09.004  0.19
2006 Zalewski C, Bonner-Jackson A, Leverenz JB. P4-127: MEDICARE COVERAGE FOR HOME HEALTH AIDE SERVICES: ADVOCATING FOR POLICY CHANGE Alzheimer's & Dementia. 14: P1487-P1487. DOI: 10.1016/J.Jalz.2018.06.2531  0.183
2016 Harrington DL, Long JD, Durgerian S, Mourany L, Koenig K, Bonner-Jackson A, Paulsen JS, Rao SM. Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27620011 DOI: 10.1002/mds.26803  0.146
2024 Bonner-Jackson A, Vangal R, Li Y, Thompson N, Chakrabarti S, Krishnan K. Factors associated with cognitive impairment in patients with persisting sequelae of Covid-19. The American Journal of Medicine. PMID 38331138 DOI: 10.1016/j.amjmed.2024.01.021  0.12
Hide low-probability matches.